The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Orthobiologics-Global Market Insights and Sales Trends 2025

Orthobiologics-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1820249

No of Pages : 120

Synopsis
The global Orthobiologics market size is expected to reach US$ 7262.8 million by 2029, growing at a CAGR of 4.6% from 2023 to 2029. The market is mainly driven by the significant applications of Orthobiologics in various end use industries. The expanding demands from the Hospitals, Ambulatory Surgical Centres and Orthopaedics Clinics,, are propelling Orthobiologics market. Bone Growth Stimulators (BGS), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Viscosupplements segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Orthobiologics market, driven by demand from China, the second largest economy with some signs of stabilising, the Orthobiologics market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Orthobiologics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Orthobiologics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Orthobiologics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Orthobiologics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Orthobiologics covered in this report include Medtronic, NuVasive, Inc., Stryker Corporation, Zimmer Biomet Holdings, Orthofix International N.V., Anika Therapeutics, Inc., DePuy Synthes (Johnson & Johnson), Bioventus and Arthrex, Inc., etc.
The global Orthobiologics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Medtronic
NuVasive, Inc.
Stryker Corporation
Zimmer Biomet Holdings
Orthofix International N.V.
Anika Therapeutics, Inc.
DePuy Synthes (Johnson & Johnson)
Bioventus
Arthrex, Inc.
SeaSpine Holdings Corporation
Sanofi-Aventis (Sanofi SA)
Djo Global, Inc.
Seikagaku Corporation
RTI Surgical, Inc.
Heraeus Holding GmbH
Fidia Pharma USA Inc.
TRB Chemedica International SA
Allosource
Musculoskeletal Transplant Foundation, Inc.
Ito
Global Orthobiologics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Orthobiologics market, Segment by Type:
Bone Growth Stimulators (BGS)
Viscosupplements
Bone Graft Substitute
Global Orthobiologics market, by Application
Hospitals
Ambulatory Surgical Centres
Orthopaedics Clinics
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Orthobiologics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Orthobiologics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Orthobiologics Market Overview
1.1 Orthobiologics Product Overview
1.2 Orthobiologics Market Segment by Type
1.2.1 Bone Growth Stimulators (BGS)
1.2.2 Viscosupplements
1.2.3 Bone Graft Substitute
1.3 Global Orthobiologics Market Size by Type
1.3.1 Global Orthobiologics Market Size Overview by Type (2018-2029)
1.3.2 Global Orthobiologics Historic Market Size Review by Type (2018-2023)
1.3.3 Global Orthobiologics Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Orthobiologics Sales Breakdown by Type (2018-2023)
1.4.2 Europe Orthobiologics Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Orthobiologics Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Orthobiologics Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Orthobiologics Sales Breakdown by Type (2018-2023)
2 Global Orthobiologics Market Competition by Company
2.1 Global Top Players by Orthobiologics Sales (2018-2023)
2.2 Global Top Players by Orthobiologics Revenue (2018-2023)
2.3 Global Top Players by Orthobiologics Price (2018-2023)
2.4 Global Top Manufacturers Orthobiologics Manufacturing Base Distribution, Sales Area, Product Type
2.5 Orthobiologics Market Competitive Situation and Trends
2.5.1 Orthobiologics Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Orthobiologics Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Orthobiologics as of 2022)
2.7 Date of Key Manufacturers Enter into Orthobiologics Market
2.8 Key Manufacturers Orthobiologics Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Orthobiologics Status and Outlook by Region
3.1 Global Orthobiologics Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Orthobiologics Historic Market Size by Region
3.2.1 Global Orthobiologics Sales in Volume by Region (2018-2023)
3.2.2 Global Orthobiologics Sales in Value by Region (2018-2023)
3.2.3 Global Orthobiologics Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Orthobiologics Forecasted Market Size by Region
3.3.1 Global Orthobiologics Sales in Volume by Region (2024-2029)
3.3.2 Global Orthobiologics Sales in Value by Region (2024-2029)
3.3.3 Global Orthobiologics Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Orthobiologics by Application
4.1 Orthobiologics Market Segment by Application
4.1.1 Hospitals
4.1.2 Ambulatory Surgical Centres
4.1.3 Orthopaedics Clinics
4.2 Global Orthobiologics Market Size by Application
4.2.1 Global Orthobiologics Market Size Overview by Application (2018-2029)
4.2.2 Global Orthobiologics Historic Market Size Review by Application (2018-2023)
4.2.3 Global Orthobiologics Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Orthobiologics Sales Breakdown by Application (2018-2023)
4.3.2 Europe Orthobiologics Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Orthobiologics Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Orthobiologics Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Orthobiologics Sales Breakdown by Application (2018-2023)
5 North America Orthobiologics by Country
5.1 North America Orthobiologics Historic Market Size by Country
5.1.1 North America Orthobiologics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Orthobiologics Sales in Volume by Country (2018-2023)
5.1.3 North America Orthobiologics Sales in Value by Country (2018-2023)
5.2 North America Orthobiologics Forecasted Market Size by Country
5.2.1 North America Orthobiologics Sales in Volume by Country (2024-2029)
5.2.2 North America Orthobiologics Sales in Value by Country (2024-2029)
6 Europe Orthobiologics by Country
6.1 Europe Orthobiologics Historic Market Size by Country
6.1.1 Europe Orthobiologics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Orthobiologics Sales in Volume by Country (2018-2023)
6.1.3 Europe Orthobiologics Sales in Value by Country (2018-2023)
6.2 Europe Orthobiologics Forecasted Market Size by Country
6.2.1 Europe Orthobiologics Sales in Volume by Country (2024-2029)
6.2.2 Europe Orthobiologics Sales in Value by Country (2024-2029)
7 Asia-Pacific Orthobiologics by Region
7.1 Asia-Pacific Orthobiologics Historic Market Size by Region
7.1.1 Asia-Pacific Orthobiologics Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Orthobiologics Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Orthobiologics Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Orthobiologics Forecasted Market Size by Region
7.2.1 Asia-Pacific Orthobiologics Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Orthobiologics Sales in Value by Region (2024-2029)
8 Latin America Orthobiologics by Country
8.1 Latin America Orthobiologics Historic Market Size by Country
8.1.1 Latin America Orthobiologics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Orthobiologics Sales in Volume by Country (2018-2023)
8.1.3 Latin America Orthobiologics Sales in Value by Country (2018-2023)
8.2 Latin America Orthobiologics Forecasted Market Size by Country
8.2.1 Latin America Orthobiologics Sales in Volume by Country (2024-2029)
8.2.2 Latin America Orthobiologics Sales in Value by Country (2024-2029)
9 Middle East and Africa Orthobiologics by Country
9.1 Middle East and Africa Orthobiologics Historic Market Size by Country
9.1.1 Middle East and Africa Orthobiologics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Orthobiologics Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Orthobiologics Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Orthobiologics Forecasted Market Size by Country
9.2.1 Middle East and Africa Orthobiologics Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Orthobiologics Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Medtronic
10.1.1 Medtronic Company Information
10.1.2 Medtronic Introduction and Business Overview
10.1.3 Medtronic Orthobiologics Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Medtronic Orthobiologics Products Offered
10.1.5 Medtronic Recent Development
10.2 NuVasive, Inc.
10.2.1 NuVasive, Inc. Company Information
10.2.2 NuVasive, Inc. Introduction and Business Overview
10.2.3 NuVasive, Inc. Orthobiologics Sales, Revenue and Gross Margin (2018-2023)
10.2.4 NuVasive, Inc. Orthobiologics Products Offered
10.2.5 NuVasive, Inc. Recent Development
10.3 Stryker Corporation
10.3.1 Stryker Corporation Company Information
10.3.2 Stryker Corporation Introduction and Business Overview
10.3.3 Stryker Corporation Orthobiologics Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Stryker Corporation Orthobiologics Products Offered
10.3.5 Stryker Corporation Recent Development
10.4 Zimmer Biomet Holdings
10.4.1 Zimmer Biomet Holdings Company Information
10.4.2 Zimmer Biomet Holdings Introduction and Business Overview
10.4.3 Zimmer Biomet Holdings Orthobiologics Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Zimmer Biomet Holdings Orthobiologics Products Offered
10.4.5 Zimmer Biomet Holdings Recent Development
10.5 Orthofix International N.V.
10.5.1 Orthofix International N.V. Company Information
10.5.2 Orthofix International N.V. Introduction and Business Overview
10.5.3 Orthofix International N.V. Orthobiologics Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Orthofix International N.V. Orthobiologics Products Offered
10.5.5 Orthofix International N.V. Recent Development
10.6 Anika Therapeutics, Inc.
10.6.1 Anika Therapeutics, Inc. Company Information
10.6.2 Anika Therapeutics, Inc. Introduction and Business Overview
10.6.3 Anika Therapeutics, Inc. Orthobiologics Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Anika Therapeutics, Inc. Orthobiologics Products Offered
10.6.5 Anika Therapeutics, Inc. Recent Development
10.7 DePuy Synthes (Johnson & Johnson)
10.7.1 DePuy Synthes (Johnson & Johnson) Company Information
10.7.2 DePuy Synthes (Johnson & Johnson) Introduction and Business Overview
10.7.3 DePuy Synthes (Johnson & Johnson) Orthobiologics Sales, Revenue and Gross Margin (2018-2023)
10.7.4 DePuy Synthes (Johnson & Johnson) Orthobiologics Products Offered
10.7.5 DePuy Synthes (Johnson & Johnson) Recent Development
10.8 Bioventus
10.8.1 Bioventus Company Information
10.8.2 Bioventus Introduction and Business Overview
10.8.3 Bioventus Orthobiologics Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Bioventus Orthobiologics Products Offered
10.8.5 Bioventus Recent Development
10.9 Arthrex, Inc.
10.9.1 Arthrex, Inc. Company Information
10.9.2 Arthrex, Inc. Introduction and Business Overview
10.9.3 Arthrex, Inc. Orthobiologics Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Arthrex, Inc. Orthobiologics Products Offered
10.9.5 Arthrex, Inc. Recent Development
10.10 SeaSpine Holdings Corporation
10.10.1 SeaSpine Holdings Corporation Company Information
10.10.2 SeaSpine Holdings Corporation Introduction and Business Overview
10.10.3 SeaSpine Holdings Corporation Orthobiologics Sales, Revenue and Gross Margin (2018-2023)
10.10.4 SeaSpine Holdings Corporation Orthobiologics Products Offered
10.10.5 SeaSpine Holdings Corporation Recent Development
10.11 Sanofi-Aventis (Sanofi SA)
10.11.1 Sanofi-Aventis (Sanofi SA) Company Information
10.11.2 Sanofi-Aventis (Sanofi SA) Introduction and Business Overview
10.11.3 Sanofi-Aventis (Sanofi SA) Orthobiologics Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Sanofi-Aventis (Sanofi SA) Orthobiologics Products Offered
10.11.5 Sanofi-Aventis (Sanofi SA) Recent Development
10.12 Djo Global, Inc.
10.12.1 Djo Global, Inc. Company Information
10.12.2 Djo Global, Inc. Introduction and Business Overview
10.12.3 Djo Global, Inc. Orthobiologics Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Djo Global, Inc. Orthobiologics Products Offered
10.12.5 Djo Global, Inc. Recent Development
10.13 Seikagaku Corporation
10.13.1 Seikagaku Corporation Company Information
10.13.2 Seikagaku Corporation Introduction and Business Overview
10.13.3 Seikagaku Corporation Orthobiologics Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Seikagaku Corporation Orthobiologics Products Offered
10.13.5 Seikagaku Corporation Recent Development
10.14 RTI Surgical, Inc.
10.14.1 RTI Surgical, Inc. Company Information
10.14.2 RTI Surgical, Inc. Introduction and Business Overview
10.14.3 RTI Surgical, Inc. Orthobiologics Sales, Revenue and Gross Margin (2018-2023)
10.14.4 RTI Surgical, Inc. Orthobiologics Products Offered
10.14.5 RTI Surgical, Inc. Recent Development
10.15 Heraeus Holding GmbH
10.15.1 Heraeus Holding GmbH Company Information
10.15.2 Heraeus Holding GmbH Introduction and Business Overview
10.15.3 Heraeus Holding GmbH Orthobiologics Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Heraeus Holding GmbH Orthobiologics Products Offered
10.15.5 Heraeus Holding GmbH Recent Development
10.16 Fidia Pharma USA Inc.
10.16.1 Fidia Pharma USA Inc. Company Information
10.16.2 Fidia Pharma USA Inc. Introduction and Business Overview
10.16.3 Fidia Pharma USA Inc. Orthobiologics Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Fidia Pharma USA Inc. Orthobiologics Products Offered
10.16.5 Fidia Pharma USA Inc. Recent Development
10.17 TRB Chemedica International SA
10.17.1 TRB Chemedica International SA Company Information
10.17.2 TRB Chemedica International SA Introduction and Business Overview
10.17.3 TRB Chemedica International SA Orthobiologics Sales, Revenue and Gross Margin (2018-2023)
10.17.4 TRB Chemedica International SA Orthobiologics Products Offered
10.17.5 TRB Chemedica International SA Recent Development
10.18 Allosource
10.18.1 Allosource Company Information
10.18.2 Allosource Introduction and Business Overview
10.18.3 Allosource Orthobiologics Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Allosource Orthobiologics Products Offered
10.18.5 Allosource Recent Development
10.19 Musculoskeletal Transplant Foundation, Inc.
10.19.1 Musculoskeletal Transplant Foundation, Inc. Company Information
10.19.2 Musculoskeletal Transplant Foundation, Inc. Introduction and Business Overview
10.19.3 Musculoskeletal Transplant Foundation, Inc. Orthobiologics Sales, Revenue and Gross Margin (2018-2023)
10.19.4 Musculoskeletal Transplant Foundation, Inc. Orthobiologics Products Offered
10.19.5 Musculoskeletal Transplant Foundation, Inc. Recent Development
10.20 Ito
10.20.1 Ito Company Information
10.20.2 Ito Introduction and Business Overview
10.20.3 Ito Orthobiologics Sales, Revenue and Gross Margin (2018-2023)
10.20.4 Ito Orthobiologics Products Offered
10.20.5 Ito Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Orthobiologics Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Orthobiologics Industrial Chain Analysis
11.4 Orthobiologics Market Dynamics
11.4.1 Orthobiologics Industry Trends
11.4.2 Orthobiologics Market Drivers
11.4.3 Orthobiologics Market Challenges
11.4.4 Orthobiologics Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Orthobiologics Distributors
12.3 Orthobiologics Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’